Tilray Brands Inc TLRY

Tilray Brands AGM - Nov 23, 2023

[DaveInCalgary]

 

Whats Up ??????  Saw a discussion on another site

Tilray getting prepared to buy up something or someone with shares?
Approval to increase the number of shares the company can issue from 990,000,000 to 1,208,000,000.
NOTE: Number of shares outstanding as of October 2023 : 629,343,158. 

Rumor: Tilray Brands Now Frontrunner To Buy Cronos Group?

https://www.youtube.com/watch?v=pkEayeH4JWk

Good informative video of POW to watch. 11 minutes  

POW - "In this video we break down some rumors in the industry regarding Cronos potentially being acquired by rival Tilray Brands Inc.
Cronos has said it is exploring sale options and with over $400M in cash Tilray could be the frontrunner.
Curaleaf Holdings has expressed interest in buying CRON but declined to comment."

NOTE: Cronos is debt free

POSTED today After hours: "$CRON and $TLRY almost same !
$CRON - 1.75USD/ share while $TLRY 1.78USD/Share. You welcome IRWIN!"

"CRON wants to be sold. Recent Rumours were that Tilray was the front runner. Cron has nearly a $1B cash and Altria owns 41% of their shares. Tilray has 1/2 of that cash plus shares but much better businesses globally. Tilray AGM next month."

A Close Look at Canadian Market Dynamics - www. zuanicassociates.com 

Gross cash balance. 

Net debt analysis notwithstanding, in some cases that debt may be quite long term in maturity, or convertible, so companies with high gross cash balances may enjoy strategic flexibility (in terms of M&A and other initiatives). 
Those with the highest gross cash balances in the Canadian group: 
CRON $1.13Bn; CGC $783Mn; TLRY $564Mn; SNDL $252Mn, and
ACB $235Mn.

Shareholder dilution. 
Several of the companies in this group issued stock in the last two years. Nothing wrong with that if it gives them strategic flexibility and is not massively dilutive over the long term.
 
https://zuanic.worldflowconnect.net/opendirect/3e543a7b-0cca-41a3-9431-bb26f309728c/230725%20Canada%20LP%20Analysis.pdf?token=4b398d33-e719-4877-9f1e-6397354cf6a9&extension=.pdf
Page 5/17 

NOTE: The High Cash Balance held by Tilray does NOT include the huge Value of  multi new or near new Greenhouses, offices & industrial properties available to Tilray from Recent mergers with others, to Repurpose Trade or $ell.
 

[DaveInCalgary]

Following question of M&A from Matt Bottomley - Cannacord has opened up some remarks about Tilrays next moves. CRON has some of those openings filled? I'm not sure how CRON is developed in Australia? Q1 2024 Earnings Call Oct 04, 2023, 8:30 a.m. ET Questions and Answers  NOTE: Tilray keeping their cards close to their chests but CRON does have Edibles that

[Ventura2020]

Tilray very bullish in Q4 comments. Q1 not so much.  Was thinking a large M&A before yearend but, the comments in Q1 are not so bullish.  The next move has to be very strategic and a massive benefit to TLRY.  CRONS(cash and Altria...possibly) has its benefits as does ACB(German market, licences).   

[DaveInCalgary]

I found the statement made by Denise Faltischek  to be the most Bullish statement made by Aphria / Tilray about German Medical Cannabis, in the +/- 8 years  Aphria / Tilray has been planning, licensing & building "We are looking to see medical cannabis in Germany become -- De scheduled as a narcotic and become a regular medicine that can be prescribed." Boris

[DaveInCalgary]

Cannabis products could soon be avaliable from NZ pharmacies From Nights, 10:35 pm on 24 October 2023 Low-dose cannabis products could soon be avaliable over the counter from New Zealand pharmacies. Usually coming in drop or capsule format - the substance can be used to treat pain, stress and anxiety. Massey University senior researcher Dr Marta Rychert runs the Annual annual